Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabigatran Treatment Following TIA and Minor Stroke
NCT01769703Phase 2Completed
- Sponsor
- University of Alberta
- Start
- Feb 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dabigatran in Transient Ischemic Attack (TIA), ischemic stroke, sponsored by University of Alberta. Started Feb 2012; status: completed.
02
Drugs
dabigatran
03
Conditions
Transient Ischemic Attack (TIA)ischemic stroke
Beyond the preview
Go deeper on NCT01769703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01769703.